A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...
Weight gain in adults due is linked to several diseases, and new research finds more Indians aged 15-49 years are obese than ...
Among adults with mild to severe obstructive sleep apnea, those receiving AD109, an oral combination drug, vs. placebo ...
Cardiovascular disease risk factor associations with social determinants of health vary significantly by nativity among Black US adults.
We transfer coverage of ResMed ( ASX: RMD ), one of the largest respiratory care device companies globally. It primarily ...
Doctors are divided on testosterone and warn many patients may not need it. Here's how to know if you actually should be on ...
NEW YORK (AP) — The cigarette smoking rate among US adults dropped to another all-time low last year, with 1 in 11 adults saying they were current smokers, according to government survey data released ...
A large new study found that not only was too little shuteye linked to accelerated biological aging, but also too much.
Amgen Inc. upgraded to cautious Buy: pipeline growth drivers, margin upside, and risk/reward near lows. Click for this AMGN ...
GLP-1 Drugs May Have a Beneficial Effect Across Many Types of Cancer By Nancy Lapid June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and ...
MedPage Today on MSNOpinion
PCOS was rebranded as PMOS. We have reservations.
While well-intentioned, the name change may have unintended consequences ...
ResMed (RMD) outlines growth catalysts in sleep & breathing health: AI, wearables, GLP-1 tailwinds, COPD, and Noctrix RLS deal—read key takeaways now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results